Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Eunice Chang"'
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 9, Pp 1973-1984 (2023)
Abstract Introduction Limited access to healthcare during the COVID-19 pandemic prompted patients to seek care using telehealth. In this study, we assessed whether treatment patterns differed for patients with psoriasis (PsO) or psoriatic arthritis (
Externí odkaz:
https://doaj.org/article/c34a4c499dbb4b3fbf5ca771e8b33e2d
Autor:
Anita D’souza, Tiffany Quock, Ansgar Conrad, Michael S Broder, Ashis K. Das, Eunice Chang, Marian H. Tarbox
Publikováno v:
HemaSphere, Vol 7, p e21770b6 (2023)
Externí odkaz:
https://doaj.org/article/a83a48310fb94a99a1863ba5ad05d1f2
Autor:
Anita D’souza, Tiffany Quock, Ansgar Conrad, Michael S. Broder, Ashis K. Das, Eunice Chang, Marian H. Tarbox
Publikováno v:
HemaSphere, Vol 7, p e2247427 (2023)
Externí odkaz:
https://doaj.org/article/eb330a1cd1a64d7b8285bbca7d2b9ad0
Autor:
Tiffany P Quock, Anita D’Souza, Michael S Broder, Katalin Bognar, Eunice Chang, Marian H Tarbox
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 2 (2022)
Aim: Describe the clinical and economic burden of hospitalizations for amyloid light chain (AL) amyloidosis. Materials & methods: This retrospective analysis used nationally representative hospital discharge data (2017–2020) to report discharge s
Externí odkaz:
https://doaj.org/article/120d60c611cf46489b43db11e9e2ffd1
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 9, Pp 1985-1985 (2023)
Externí odkaz:
https://doaj.org/article/c855f6ea00f84cae81d9d1502be7316f
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Despite emerging treatments for hereditary transthyretin (ATTRv) amyloidosis, the disease is often misdiagnosed, with reported diagnostic delays of up to several years. Knowledge of the patient journey leading up to diagnosis may
Externí odkaz:
https://doaj.org/article/26416dab31d04b7eb5fd24a4e7ed5037
Autor:
Sheila R. Reddy, Eunice Chang, Marian H. Tarbox, Michael S. Broder, Ryan S. Tieu, Spencer Guthrie, Montserrat Vera-Llonch, Michael R. Pollock
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 473-482 (2020)
Abstract Introduction Little is known about the burden of hereditary transthyretin (ATTRv) amyloidosis, a genetic, progressive, and fatal disease caused by extracellular deposition of transthyretin amyloid fibrils. The study’s aim was to estimate c
Externí odkaz:
https://doaj.org/article/0bc7bd40c9b34317963e69412f7b4102
Autor:
Xue Han, Francis Lobo, Michael S. Broder, Eunice Chang, Sarah N. Gibbs, David J. Ridley, Irina Yermilov
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 8, Iss 1 (2021)
**Background:** Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling and destruction that leads to severe disability. There are no clear guidelines regarding the order of therapies. Gathering data on treatment p
Externí odkaz:
https://doaj.org/article/34f50d8428814820bf54bb8dbc39fdee
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background As reported in Surveillance, Epidemiology, and End Results (SEER) data, US incidence and prevalence of neuroendocrine tumors (NET) has increased over recent years. The study objective was to update incidence and prevalence informa
Externí odkaz:
https://doaj.org/article/eb7ce38e6bdc49d585b2062f2903c367
Publikováno v:
Blood Advances, Vol 2, Iss 10, Pp 1046-1053 (2018)
Abstract: Amyloid light-chain (AL) amyloidosis is a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to provide an up-to-date estimate of prevalence and incidence of AL amyloidosis in the Unit
Externí odkaz:
https://doaj.org/article/19bebe0d4fd144d7a600e783c6da03d9